Cytosorbents Corporation

NASDAQ: CTSO · Real-Time Price · USD
1.14
0.00 (0.00%)
At close: Aug 15, 2025, 12:07 PM

Cytosorbents Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.28M 14.13M 22.14M 52.14M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
1.48M 1.48M 1.73M 1.94M
Other Long-Term Assets
22.64K 52.05K 1.73M 1.94M
Receivables
7.32M 6.06M 5.66M 4.52M
Inventory
2.73M 3.38M 3.46M 4.77M
Other Current Assets
8.27M n/a 462.00 -85
Total Current Assets
21.6M 25.4M 33.76M 64.3M
Property-Plant & Equipment
20.51M 22.12M 23.35M 18.57M
Goodwill & Intangibles
3.75M 3.91M 4.39M 4.7M
Total Long-Term Assets
25.77M 27.56M 29.47M 25.22M
Total Assets
47.37M 52.96M 63.23M 89.52M
Account Payables
3.34M 3.8M 1.66M 2.81M
Deferred Revenue
419.33K 1.38M 1.52M 1.95M
Short-Term Debt
452.69K 2.5M 108.94K 570.57K
Other Current Liabilities
412.82K 991.54K -108.49K 687.5K
Total Current Liabilities
9.82M 14.04M 9.71M 13.69M
Long-Term Debt
14M 2.54M 5M n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
26.44M 15.44M 18.14M 13.25M
Total Liabilities
36.26M 29.48M 27.86M 26.94M
Total Debt
26.89M 18.31M 18.25M 13.82M
Common Stock
54.83K 54.24K 43.63K 43.48K
Retained Earnings
-304.01M -282.51M -254M -221.19M
Comprehensive Income
4.25M 529.32K 2.33M 525.59K
Shareholders Equity
11.11M 23.48M 35.38M 62.58M
Total Investments
1.48M 1.48M 1.73M 1.94M